Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Endonovo Therapeutics Inc (ENDV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,204
  • Shares Outstanding, K 494,824
  • Annual Sales, $ 0 K
  • Annual Income, $ -10,810 K
  • 60-Month Beta 2.49
  • Price/Sales 230.10
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/19/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0178 +6.18%
on 03/11/19
0.0243 -22.22%
on 02/21/19
-0.0050 (-20.92%)
since 02/19/19
3-Month
0.0165 +14.55%
on 01/02/19
0.0409 -53.79%
on 01/15/19
-0.0011 (-5.50%)
since 12/19/18
52-Week
0.0150 +26.00%
on 08/14/18
0.0661 -71.41%
on 10/03/18
-0.0180 (-48.78%)
since 03/19/18

Most Recent Stories

More News
Endonovo Therapeutics Announces New Website Launch

The completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse(R)

ENDV : 0.0181 (-2.69%)
Endonovo Therapeutics Files Lawsuit against KVP International Inc., Orthocor Medical Inc., and Careus Corp. for Patent Infringement

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, filed a patent infringement lawsuit today...

ENDV : 0.0181 (-2.69%)
Innovative Developments in Biotechnology set to Spur the Market Growth

NEW YORK, January 23, 2019 /PRNewswire/ --

NMUS : 0.5300 (+3.11%)
PMCB : 0.0485 (-3.00%)
ENDV : 0.0181 (-2.69%)
SNET : 0.0106 (-43.92%)
ATBPF : 0.2046 (+0.39%)
Endonovo Therapeutics Issues Shareholder Letter and Update

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announced the issuance of the following...

ENDV : 0.0181 (-2.69%)
The Next Big Biotech Breakout

HENDERSON, NV / ACCESSWIRE / January 8, 2019 / Celgene's major deal with Bristol-Myers Squibb seems to have woken up the sleeping giant that is the biotech market. Axsome announced positive trial data...

GNMX : 0.23 (unch)
ENDV : 0.0181 (-2.69%)
CELGZ : 1.13 (-1.74%)
HSGX : 0.15 (+25.00%)
BMY : 49.72 (-0.28%)
AXSM : 12.75 (+11.16%)
Biotech Rally Ahead of the Market

HENDERSON, NV / ACCESSWIRE / January 2, 2019 / Biotech hit its bear market phase weeks before the market as a whole did. Some analysts think this means the turnaround will come sooner. Here's a few biotech...

VTVT : 1.92 (-4.00%)
ENDV : 0.0181 (-2.69%)
GILD : 65.65 (+0.97%)
PTLA : 33.45 (+1.21%)
Biotech Companies in the News

HENDERSON, NV / ACCESSWIRE / December 31, 2018 / Several biotech companies have released major announcements this holiday season setting themselves up for a strong start to 2019.

VTVT : 1.92 (-4.00%)
ENDV : 0.0181 (-2.69%)
OPK : 2.54 (+0.79%)
Biotech News Driving These Companies

HENDERSON, NV / ACCESSWIRE / December 26, 2018 / The news isn't all gloom and doom, the biotech companies highlighted below have all released positive news recently.

ARQL : 4.81 (+0.63%)
ADIL : 2.96 (-1.66%)
ENDV : 0.0181 (-2.69%)
ACOR : 14.46 (+0.49%)
EARS : 0.36 (-2.70%)
Major Biotech Deals Making Sector Red Hot

HENDERSON NV / ACCESSWIRE / December 21, 2018 / Deals like the partnership between Gilead and Agenus are making the biotech industry red hot. Here are some biotech companies to look into.

AGEN : 2.90 (+0.69%)
CELG : 88.70 (+0.81%)
ENDV : 0.0181 (-2.69%)
NVAX : 0.51 (-1.92%)
GILD : 65.65 (+0.97%)
Biotech Stocks Set to Breakout

HENDERSON, NV / ACCESSWIRE / December 20, 2018 / Here is a list of several Biotech companies with announcements that could move their markets in the coming sessions.

ENDV : 0.0181 (-2.69%)
NVAX : 0.51 (-1.92%)
CELGZ : 1.13 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ENDV with:

Key Turning Points

2nd Resistance Point 0.0221
1st Resistance Point 0.0203
Last Price 0.0181
1st Support Level 0.0175
2nd Support Level 0.0165

See More

52-Week High 0.0661
Fibonacci 61.8% 0.0466
Fibonacci 50% 0.0406
Fibonacci 38.2% 0.0345
Last Price 0.0181
52-Week Low 0.0150

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar